Healthy Men for Investigational Drug Being Developed for Cancer
The study drug is an investigational drug being developed for the treatment of cancer. An investigational drug is a drug that has not been approved by the U.S. Food and Drug Administration (FDA).
This type of study is called a radiolabeled study. For this study, the study drug has been specially prepared to contain radiolabeled carbon [14C]. [14C] is a naturally occurring radioactive form of the element carbon. Adding a low dose of radiation to the study drug does not change how the drug works, but helps us to see how the drug appears in the blood, urine, and stool after it is given to you.
- Apr. 27 – May 11, 2023
Study involves 1 stay of 7 to 14 nights and administration of investigational medication
- Check-In: April 27
- Minimum Stay: May 4
- Check-Out: May 11
- Compensation up to $4,480 to $7,525 may be provided for time and participation
- Receive up to $200 per qualified participant
- Healthy Men
- Age 18-55
- Body Mass Index between 18-32